Hrubá marže společnosti Acorda Therapeutics Inc

Jaká je hodnota metriky Hrubá marže společnosti Acorda Therapeutics Inc?

Hodnota metriky Hrubá marže společnosti Acorda Therapeutics Inc je 87.01%

Jaká je definice metriky Hrubá marže?



Hrubá marže (Gross margin) je rozdíl mezi příjmy a náklady na prodané zboží dělený příjmy a vyjádřený v procentech.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Hrubá marže společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Acorda Therapeutics Inc

Čemu se věnuje společnost Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Firmy s metrikou hrubá marže podobnou společnosti Acorda Therapeutics Inc